Actinium Pharmaceuticals
ATNM
#9653
Rank
NZ$71.9 M
Marketcap
$2.30
Share price
-7.19%
Change (1 day)
-84.78%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -NZ$72.67 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.08 Million. In 2023 the company made an earning of -NZ$92.77 Million a decrease over its 2022 earnings that were of -NZ$60.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$72.67 Million-21.66%
2023 -NZ$92.77 Million52.24%
2022 -NZ$60.94 Million36.61%
2021 -NZ$44.61 Million11.48%
2020 -NZ$40.01 Million1.46%
2019 -NZ$39.44 Million-7.37%
2018 -NZ$42.58 Million-11.46%
2017 -NZ$48.09 Million10.67%
2016 -NZ$43.45 Million15.7%
2015 -NZ$37.56 Million-14.86%
2014 -NZ$44.11 Million129.19%
2013 -NZ$19.25 Million-8.55%
2012 -NZ$21.05 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$66.45 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.96 B-1,305.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$51.38 Million-36.04%๐Ÿ‡บ๐Ÿ‡ธ USA